REGENXBIO Inc. (RGNX) Social Stream
REGENXBIO INC (RGNX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering REGENXBIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 9 | $90 | $43 | $63.571 | $23.21 | 173.89% |
| 2022-01-10 | 8 | $90 | $29 | $59.25 | $23.21 | 155.28% |
| 2022-02-01 | 8 | $90 | $29 | $58.25 | $23.21 | 150.97% |
| 2022-02-14 | 8 | $90 | $29 | $57.5 | $23.21 | 147.74% |
| 2022-03-04 | 8 | $90 | $25 | $57 | $23.21 | 145.58% |
| 2022-03-22 | 7 | $82 | $25 | $52.428 | $23.21 | 125.89% |
| 2022-03-29 | 7 | $82 | $25 | $55.375 | $23.21 | 138.58% |
| 2022-04-11 | 8 | $82 | $25 | $55.375 | $23.21 | 138.58% |
| 2022-05-06 | 8 | $82 | $25 | $54.625 | $23.21 | 135.35% |
| 2022-06-10 | 8 | $82 | $25 | $54.125 | $23.21 | 133.2% |
| 2022-07-11 | 10 | $82 | $25 | $54.1 | $23.21 | 133.09% |
| 2022-08-04 | 10 | $82 | $25 | $54.4 | $23.21 | 134.38% |
| 2022-08-31 | 10 | $82 | $25 | $54.3 | $23.21 | 133.95% |
| 2022-10-03 | 8 | $70 | $25 | $51.5 | $23.21 | 121.89% |
| 2022-10-04 | 9 | $70 | $25 | $48.555 | $23.21 | 109.2% |
| 2022-10-25 | 9 | $70 | $13 | $47.222 | $23.21 | 103.46% |
| 2022-11-04 | 9 | $65 | $13 | $44.555 | $23.21 | 91.96% |
| 2022-11-06 | 9 | $65 | $14 | $44.666 | $23.21 | 92.44% |
| 2022-11-21 | 9 | $65 | $14 | $44.444 | $23.21 | 91.49% |
| 2022-11-30 | 9 | $65 | $15 | $44.555 | $23.21 | 91.96% |
| 2022-12-15 | 9 | $65 | $15 | $44 | $23.21 | 89.57% |
| 2023-01-27 | 9 | $65 | $14 | $43.889 | $23.21 | 89.1% |
The Trend in the Analyst Price Target
RGNX's average price target has moved down $19.68 over the prior 15 months.
Over the past 51 weeks, RGNX's average upside potential has been 102.33%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-10 | 10 | 82 | 25 | 54.300 | 34.66 | 56.66% |
| 2022-09-13 | 8 | 70 | 25 | 51.500 | 26.33 | 95.59% |
| 2022-09-17 | 8 | 70 | 25 | 51.500 | 25.98 | 98.23% |
| 2022-10-03 | 8 | 70 | 25 | 51.500 | 24.17 | 113.07% |
| 2022-11-06 | 9 | 65 | 14 | 44.666 | 20.73 | 115.47% |
RGNX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 6 | 0 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 39 weeks, RGNX's average broker recommendation rating improved by 0.21.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, REGENXBIO INC's variance in analysts' estimates is lower than -2016.71% of them.
- REGENXBIO INC's upside potential (average analyst target price relative to current price) is greater than 1909.73% of all US stocks.
- RGNX has a higher average analyst price target than 1685.09% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENXBIO INC's number of analysts covering the stock is higher than 1624.33% of them.
Stocks similar to REGENXBIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FATE, IOVA, and NSTG.
View All Top Stocks by Price Target
Is RGNX a Buy, Hold or Sell? See the POWR Ratings now!